Capital Investment to Bio-Venture Company; Delta-Fly Pharma, Inc.

  • 2018/03/29 News

Sanyo Chemical Industries, Ltd. (HQ: Kyoto, Japan, President: Takao Ando) has made a capital investment to Delta-Fly Pharma Inc. (HQ: Tokushima, Japan, President: Kiyoshi Eshima) on March 23rd, 2018 through a third-party allotment of shares. Also both companies made the Collaboration Agreement for the Development of Novel Oncology Products innovative for cancer patients dated March 28th, 2018. Delta-Fly Pharma Inc. is a bio-pharmaceutical venture company which is developing the novel anti-cancer agents to reduce physical and economic burden of patients. (34KB)